TD Capital Management’s AbbVie ABBV Stock Holding History

TD Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$197K	Buy	784 +6	+0.8%	+$1.29K	0.02%	143
2026 Q1	$169K	Sell	778 -44	-5%	-$9.76K	0.02%	147
2025 Q4	$188K	Buy	822 +137	+20%	+$31.2K	0.02%	129
2025 Q3	$159K	Buy	685 +5	+0.7%	+$1.02K	0.01%	138
2025 Q2	$126K	Buy	680 +552	+431%	+$103K	0.01%	146
2025 Q1	$26.8K	Buy	128 +58	+83%	+$11.3K	﹤0.01%	231
2024 Q4	$12.5K	Buy	70 +16	+30%	+$2.94K	﹤0.01%	272
2024 Q3	$10.8K	Hold	54	–	–	﹤0.01%	284
2024 Q2	$9.27K	Hold	54	–	–	﹤0.01%	283
2024 Q1	$9.75K	Buy	54 +1	+2%	+$172	﹤0.01%	286
2023 Q4	$8.22K	Sell	53 -340	-87%	-$49.6K	﹤0.01%	296
2023 Q3	$58.5K	Buy	393 +4	+1%	+$587	0.01%	161
2023 Q2	$52.4K	Buy	389 +3	+0.8%	+$440	0.01%	171
2023 Q1	$61.4K	Sell	386 -21	-5%	-$3.21K	0.01%	161
2022 Q4	$65.7K	Buy	407 +29	+8%	+$4.45K	0.01%	144
2022 Q3	$51K	Buy	+378	New	+$54.2K	0.01%	159
2022 Q1	–	Sell	-439	Closed	-$59K	–	95
2021 Q4	$59K	Sell	439 -106	-19%	-$12.5K	0.01%	152
2021 Q3	$59K	Buy	545 +4	+0.7%	+$457	0.01%	145
2021 Q2	$61K	Buy	541 +5	+0.9%	+$563	0.01%	135
2021 Q1	$58K	Buy	536 +126	+31%	+$13.5K	0.01%	130
2020 Q4	$44K	Buy	410 +5	+1%	+$480	0.01%	135
2020 Q3	$35K	Buy	+405	New	+$38.1K	0.01%	133
2019 Q3	–	Sell	-455	Closed	-$33K	–	259
2019 Q2	$33K	Buy	+455	New	+$35.8K	0.01%	123
2017 Q4	–	Sell	-112	Closed	-$10K	–	183
2017 Q3	$10K	Buy	+112	New	+$8.53K	﹤0.01%	134

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TD Capital Management's ABBV Position: Q2 2026 in Review

TD Capital Management increased its AbbVie (ABBV) stake by 0.77% in Q2 2026, buying an estimated $1.29K and bringing the position to 784 shares worth $197K. The position accounts for 0.02% of the portfolio, ranked #143.

TD Capital Management first reported a position in ABBV in Q3 2017 and has held it in 24 quarters since. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

TD Capital Management held 784 shares of AbbVie worth $197K as of Q2 2026.
TD Capital Management bought 6 AbbVie shares in Q2 2026, an estimated $1.29K.
AbbVie made up 0.02% of TD Capital Management's portfolio in Q2 2026, its #143 holding.
TD Capital Management first reported a position in AbbVie in Q3 2017 and has held it in 24 quarters since.
4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TD Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.